An evidence gap exists in comparing the effectiveness of angiotensin receptor II blockers
(ARBs) for hypertension with that of angiotensin‐converting enzyme inhibitors (ACEIs). We …

J Clin Hypertens (Greenwich). 2012; 14: 407–414.© 2012 Wiley Periodicals, Inc. Important
questions concerning the comparative effectiveness of angiotensin‐converting enzyme …

ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers (ARBs)
are equally guideline-recommended first-line treatments for hypertension, yet few head-to …

BACKGROUND Angiotensin II receptor blockers (ARBs) and angiotensin‐converting
enzyme inhibitors (ACEIs) block distinct components of the renin‐angiotensin system …

Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers | AAFP
Advertisement search close brand logo BACHIR TAZKARJI, MD, AND AMBIKA …

Most guidelines for the management of patients with cardiovascular disease recommend
angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas …

Two independent pharmacologic methods of specifically interfering with the renin-
angiotensin-aldosterone system have been brought to the marketplace: angiotensin …

Inhibitors of the renin-angiotensin system remain a cornerstone of cardiovascular
pharmacotherapy. Although angiotensin converting enzyme inhibitors (ACEIs) have been …

Abstract Purpose of Review Angiotensin-converting enzyme inhibitors and angiotensin
receptor blockers are commonly used anti-hypertensive medications in a number of clinical …

In this article, 2 leading physicians debate the strength of outcome data on the efficacy of
angiotensin-converting enzyme (ACE) inhibitors versus angiotensin II receptor blockers …